Cathay International Holdings Ld Lansen's Interim Results (3686X)
27 Agosto 2020 - 10:33AM
UK Regulatory
TIDMCTI
RNS Number : 3686X
Cathay International Holdings Ld
27 August 2020
Cathay International Holdings Limited
( " Cathay " or the "Company " )
Lansen reports interim results for the six months ended 30 June
2020
Hong Kong, 27 August 2020 - Cathay International Holdings L imi
t e d (LSE: CTI.L) , an operator and investor in the growing
healthcare sector in the People ' s Republic of China, today notes
that Lansen Pharmaceutical Holdings Ltd ("Lansen") (HKEX: 503), the
Company's 52.83% owned subsidiary, has reported its interim results
for the six months ended 30 June 2020 in accordance with the
requirements of its Hong Kong listing.
The full text of the Lansen Announcement can be found at
https://www1.hkexnews.hk/listedco/listconews/sehk/2020/0827/2020082701536.pdf
and will also be made available at Announcements & Notices
section of Lansen's homepage at
http://holding.lansen.com.cn//en/newslist.aspx?NodeCode=10002000700050005
.
As previously announced, Cathay will issue its Interim Results
for the six months ended 30 June 2020 on Friday 28 August 2020.
-Ends-
For further enquiries, please contact:
Cathay International Holdings Limited
Eric Siu (Finance Director) Tel: +852 2828 9289
Patrick Sung (Director and Controller)
SPARK Advisory Partners Limited (sponsor)
Andrew Emmott / James Keeshan Tel: +44 (0) 20 3368 3555
About Cathay
Cathay International Holdings Limited (LSE: CTI.L) is a main
market listed investment holding company and an operator and
investor in the healthcare sector in the People's Republic of China
(the "PRC"). The Company and its subsidiaries (collectively the
"Group") aim to leverage on investment opportunities in the growing
domestic demand for high quality healthcare products in the PRC and
build portfolio companies into market sector leaders with
competitive edge. Cathay has already demonstrated a track record of
identifying investment opportunities in this area including:
Lansen, a leading specialty pharmaceutical company focused on
rheumatology and dermatology in the PRC; Haizi, a company engaged
in the manufacture, marketing and sale of inositol and its
by-product, di-calcium phosphate; Natural Dailyhealth, a company
engaged in production and sales of plant extracts for use as key
active ingredients in healthcare products; and Botai, a company
engaged in collagen products.
The Group employs approximately 1,300 people across the PRC,
including over 20 specialist corporate and business development
staff based at the holding company's offices in Hong Kong and
Shenzhen. Cathay also has a hotel investment. For more information
please visit the Company's website: www.cathay-intl.com.hk.
About Lansen
Lansen, whose shares are listed on the main board of the Hong
Kong Stock Exchange, is a 52.83% owned subsidiary of Cathay. Lansen
is engaged in the manufacture, distribution and development of
specialty prescription drugs for treatment of autoimmune disorder
in rheumatology and dermatology. Lansen has established an
extensive distribution network, covering more than 1,500 hospitals
in four municipalities, 22 provinces and cities in the PRC. For
more information please visit the Lansen's website:
www.lansen.com.cn/en/index.aspx.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
DOCKKOBNNBKDKFB
(END) Dow Jones Newswires
August 27, 2020 09:33 ET (13:33 GMT)
Cathay International Hol... (LSE:CTI)
Gráfico Histórico do Ativo
De Abr 2024 até Mai 2024
Cathay International Hol... (LSE:CTI)
Gráfico Histórico do Ativo
De Mai 2023 até Mai 2024